Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective phase 3 study of Rekovelle for ovulation induction or ovarian stimulation in intrauterine insemination
MOH_2022-10-06_012091Phase 3Not yet recruiting
- Sponsor
- פרופ' אבי בן הרוש
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of recombinant human follicle stimulating hormone in female infertility, anovulation, polycystic ovary syndrome (PCOS) and 2 more (2 arms), sponsored by פרופ' אבי בן הרוש. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
female infertilityanovulationpolycystic ovary syndrome (PCOS)Unexplained infertilitymale infertility
Beyond the preview
Go deeper on MOH_2022-10-06_012091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-10-06_012091.